查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2158682

心肺支持膜式氧合裝置市場：全球市場預測，2026-2032年

Cardiopulmonary Assisted Membrane Oxygenator Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心肺支撐膜氧合裝置的市場規模將成長至 31.1 億美元，複合年成長率為 9.19%。

主要市場統計數據
基準年 2025 16.8億美元
預計年份：2026年 18.4億美元
預測年份 2032 31.1億美元
複合年成長率 (%) 9.19%

心肺支持膜式氧合裝置：概述

心肺支持膜式氧合器（CPR）可在肺部或心肺系統無法維持足夠的氧合和二氧化碳清除時輔助體外氣體交換。其應用範圍涵蓋心臟手術、體外維生、重症監護以及某些急救領域。其臨床價值取決於可靠的氧氣輸送、血液相容性、監測、灌注技術以及與更廣泛的CPR支持方案的整合。

臨床工作流程正朝著一體化、先進的急救支援方向發展。

隨著快速部署、多學科協作和標準化體外生命支持方案的重要性日益凸顯，該領域正在蓬勃發展。醫院擴大將氧合器視為與主機、幫浦、感測器、抗凝血方案和一次性零件配合使用，而非獨立組件。關鍵的操作重點包括減少血液負荷、簡化迴路、確保可靠的預充和連接程序，以及增強從設置到使用的可追溯性。

人工智慧正在增強監控、預測和工作流程管理。

人工智慧能夠及早識別壓力、流速、氧合、溫度或氣體交換方面的異常模式，而這些異常模式僅靠人工檢查可能難以發現，從而提升醫療價值。預測模型若能經過臨床檢驗，並附有清晰的不確定性指標，則有助於醫療團隊識別血栓超負荷、膜功能障礙、氧氣供應問題或患者-迴路不匹配等問題的進展。

區域洞察：六種醫療保健環境下的可近性和能力差異

在北美，先進的心臟和重症監護基礎設施以及成熟的體外循環項目正在融合，採購也越來越注重實證醫學、服務支援和整體營運可靠性。在歐洲，臨床管治、監管協調和跨國標準備受重視，但不同醫療體系的准入和人員配備有差異。

群體特定洞察：經濟和安全障礙影響臨床應對力

東南亞國協醫療體系、法規環境和專業能力的差異，要求訓練和分發模式具有高度的適應性。金磚國家擁有重要的製造、研究和臨床生態系統，但在醫保報銷、採購和心肺體外迴圈服務取得方面存在顯著差異。歐盟受益於協調一致的監管原則和臨床合作，但具體實施仍取決於各國的醫療體系和醫院能力。

國家概況：國家能力決定部署優先事項

澳洲重視專科轉診網路、臨床管治以及面向地域分散人口的服務提供。巴西和墨西哥的主要都市區與廣泛的公共醫療網路之間存在醫療資源取得方面的差距，因此培訓、後勤保障和成本效益至關重要。加拿大和美國已建立提供先進醫療服務的機構，重點關注治療結果的證據、人員配備、醫療服務的連續性以及與複雜心臟病和重症監護路徑的整合。

產業優先事項：建立更安全、更易於實施且具有強大支援的系統。

領導者應優先考慮具有臨床意義的表現指標，例如氣體交換、血液相容性、壓力穩定性、設定時間、可靠性和併發症監測。產品設計必須支援直覺的連接、清晰的狀態指示器、可靠的警報邏輯，並與現有的泵浦、主機、感測器和醫院資訊系統相容。

調查方法：整合有關臨床、監管和營運因素的證據。

本執行摘要以既定的市場定義和必要的地域分類為分析框架，整合了關於體外生命支持、心肺體外迴圈、重症監護、醫療設備法規、臨床工作流程以及醫療保健系統現狀等方面的既有考慮。

結論：臨床可靠性和系統開發狀況將決定進展。

心肺支持膜式氧合系統（CEM）只有在其可靠的性能與技術精湛的團隊、嚴格的操作規程、完善的供應和服務體係以及合適的患者選擇相結合時，才能真正發揮其價值。因此，該領域的發展涉及技術和組織兩個方面。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：心肺支持膜氧合裝置市場：依產品類型分類

  • 拋棄式的
    • 聚甲基戊烯
    • 聚丙烯
    • 矽酮
  • 可重複使用的
    • 聚甲基戊烯
    • 聚丙烯
    • 矽酮

第8章：心肺支持膜氧合裝置市場：依應用分類

  • 成人
    • 心臟衰竭
    • 呼吸衰竭
  • 新生
  • 兒童

第9章：心肺支持膜式氧合裝置市場：依操作模式分類

  • 動脈和靜脈
  • 靜脈-動脈型
  • 靜脈-靜脈型

第10章：心肺支持膜氧合裝置市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 私人的
    • 民眾
  • 專科診所

第11章：心肺支持膜氧合裝置市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：心肺支持膜氧合裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：心肺支持膜氧合裝置市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Asahi Kasei Medical Co., Ltd.
  • Braile Biomedica
  • Chalice Medical Ltd
  • Eurosets Srl
  • Fresenius SE & Co. KGaA
  • Getinge AB
  • Hemovent GmbH
  • Kewei Medical
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Terumo Corporation
  • Xenios AG

第16章 主要專家

Product Code: MRR-4654A89DBB83

The Cardiopulmonary Assisted Membrane Oxygenator Market is projected to grow by USD 3.11 billion at a CAGR of 9.19% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.68 billion
Estimated Year [2026] USD 1.84 billion
Forecast Year [2032] USD 3.11 billion
CAGR (%) 9.19%

Cardiopulmonary Assisted Membrane Oxygenators: Executive Overview

Cardiopulmonary assisted membrane oxygenators support extracorporeal gas exchange when the lungs or heart-lung system cannot adequately maintain oxygenation and carbon-dioxide removal. Their use spans cardiac surgery, extracorporeal life support, intensive care, and selected emergency applications. Clinical value depends on dependable oxygen transfer, blood compatibility, monitoring, perfusion expertise, and integration with broader cardiopulmonary support protocols.

Clinical Workflows Are Shifting Toward Integrated, High-Acuity Support

The field is being shaped by greater emphasis on rapid deployment, multidisciplinary coordination, and standardized extracorporeal life-support pathways. Hospitals increasingly evaluate oxygenators alongside consoles, pumps, sensors, anticoagulation protocols, and disposables rather than as isolated components. Key operational priorities include lower blood trauma, reduced circuit complexity, reliable priming and connection procedures, and stronger traceability throughout setup and use.

Regulatory scrutiny and post-market vigilance also influence product development. Evidence requirements increasingly address safety, durability, hemocompatibility, infection control, usability, and performance across patient populations. Workforce capability remains decisive because outcomes depend on trained perfusionists, intensivists, nurses, surgeons, and biomedical support teams working from consistent protocols.

Artificial Intelligence Is Strengthening Monitoring, Prediction, and Workflow Control

Artificial intelligence can add value by identifying abnormal pressure, flow, oxygenation, temperature, or gas-exchange patterns earlier than manual review alone. Predictive models may help teams recognize developing clot burden, membrane dysfunction, oxygen-delivery problems, or patient-circuit mismatch, provided that outputs are validated clinically and presented with clear uncertainty indicators.

The cumulative effect is likely to be strongest in decision support rather than autonomous control. AI-enabled systems can consolidate circuit and patient data, reduce alarm fatigue, support documentation, and assist training through simulated scenarios. Safe adoption requires representative datasets, cybersecurity, explainable alerts, human oversight, interoperability with hospital systems, and prospective evaluation of whether tools improve patient outcomes without increasing workflow burden.

Regional Insights: Access and Capability Differ Across Six Care Environments

North America combines advanced cardiac and critical-care infrastructure with established extracorporeal programs, while procurement increasingly emphasizes evidence, service support, and total operating reliability. Europe places strong weight on clinical governance, harmonized regulation, and cross-border standards, although access and staffing vary among health systems.

Asia-Pacific includes highly developed specialist centers alongside rapidly expanding critical-care capacity, creating differing requirements for training, portability, and maintenance. Latin America's adoption is influenced by referral concentration, import logistics, reimbursement conditions, and availability of perfusion expertise. The Middle East is building specialized tertiary capacity, with demand shaped by centralized procurement and investment in complex-care hubs. Africa shows substantial variation between urban referral hospitals and areas with limited intensive-care infrastructure, making durability, training, and serviceability especially important.

Group Insights: Economic and Security Blocs Shape Clinical Readiness

ASEAN presents a diverse mix of healthcare systems, regulatory environments, and specialist capacity, favoring adaptable training and distribution models. BRICS countries span major manufacturing, research, and clinical ecosystems but differ considerably in reimbursement, procurement, and access to perfusion services. The European Union benefits from coordinated regulatory principles and clinical collaboration, while implementation remains dependent on national systems and hospital capabilities.

G7 members generally have mature cardiac and intensive-care programs, with priorities centered on safety evidence, workforce efficiency, digital integration, and lifecycle support. GCC countries are strengthening advanced tertiary-care capacity and may favor centralized centers of excellence. NATO countries encompass varied health systems, but shared attention to emergency preparedness, supply resilience, interoperability, and rapid critical-care response can influence technology planning.

Country Insights: National Capacity Determines Adoption Priorities

Australia emphasizes specialist referral networks, clinical governance, and service coverage across geographically dispersed populations. Brazil and Mexico face varied access between leading urban centers and broader public-care networks, making training, logistics, and affordability important. Canada and the United States have established advanced-care institutions, with attention to outcomes evidence, staffing, supply continuity, and integration into complex cardiac and critical-care pathways.

China, India, Japan, and South Korea combine substantial hospital capacity with distinct regulatory and procurement environments; priorities include domestic capability, specialist training, quality assurance, and scalable support models. France, Germany, Italy, Spain, and the United Kingdom focus on evidence-based use, system efficiency, and coordination across tertiary and regional services. Russia's requirements are influenced by domestic supply resilience, specialist availability, and the operating needs of major referral institutions.

Industry Priorities: Build Safer, More Deployable, and Better-Supported Systems

Leaders should prioritize clinically meaningful performance measures, including gas exchange, blood compatibility, pressure stability, setup time, reliability, and complication monitoring. Product design should support intuitive connections, clear status visibility, robust alarm logic, and compatibility with established pumps, consoles, sensors, and hospital information systems.

Organizations should pair product development with structured education for perfusion, surgical, intensive-care, and nursing teams. Regional service networks, validated maintenance procedures, contingency inventory, and transparent post-market surveillance can improve operational resilience. AI investments should begin with narrowly defined, high-value monitoring or documentation use cases and progress only after validation, cybersecurity review, usability testing, and prospective clinical assessment.

Methodology: Evidence-Based Synthesis of Clinical, Regulatory, and Operational Factors

This executive summary uses the specified market definition and required geographic groupings as an analytical framework. It synthesizes established considerations in extracorporeal support, cardiopulmonary bypass, intensive-care delivery, medical-device regulation, clinical workflow, and health-system readiness.

The assessment is qualitative and deliberately excludes market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims. Regional, group, and country observations reflect differences in clinical infrastructure, workforce, regulation, procurement, reimbursement, logistics, and digital readiness. Conclusions should be tested against current peer-reviewed evidence, regulatory publications, clinical guidelines, and institution-level data before investment or implementation decisions.

Conclusion: Clinical Reliability and System Readiness Will Define Progress

Cardiopulmonary assisted membrane oxygenators are most valuable when dependable device performance is matched with skilled teams, disciplined protocols, resilient supply and service systems, and appropriate patient selection. The sector's development is therefore both technological and organizational.

Future progress will depend on evidence that connects engineering improvements with meaningful clinical outcomes and practical workflow gains. Regional adaptation, workforce development, interoperability, and carefully governed AI can expand the benefits of extracorporeal support while preserving safety, accountability, and patient-centered care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cardiopulmonary Assisted Membrane Oxygenator Market, by Product Type

  • 7.1. Introduction
  • 7.2. Disposable
    • 7.2.1. Polymethylpentene
    • 7.2.2. Polypropylene
    • 7.2.3. Silicone
  • 7.3. Reusable
    • 7.3.1. Polymethylpentene
    • 7.3.2. Polypropylene
    • 7.3.3. Silicone

8. Cardiopulmonary Assisted Membrane Oxygenator Market, by Application

  • 8.1. Introduction
  • 8.2. Adult
    • 8.2.1. Cardiac Failure
    • 8.2.2. Respiratory Failure
  • 8.3. Neonatal
  • 8.4. Pediatric

9. Cardiopulmonary Assisted Membrane Oxygenator Market, by Mode of Operation

  • 9.1. Introduction
  • 9.2. Arteriovenous
  • 9.3. Venoarterial
  • 9.4. Venovenous

10. Cardiopulmonary Assisted Membrane Oxygenator Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Hospitals
    • 10.3.1. Private
    • 10.3.2. Public
  • 10.4. Specialty Clinics

11. Cardiopulmonary Assisted Membrane Oxygenator Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Cardiopulmonary Assisted Membrane Oxygenator Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Cardiopulmonary Assisted Membrane Oxygenator Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Asahi Kasei Medical Co., Ltd.
  • 15.2. Braile Biomedica
  • 15.3. Chalice Medical Ltd
  • 15.4. Eurosets S.r.l.
  • 15.5. Fresenius SE & Co. KGaA
  • 15.6. Getinge AB
  • 15.7. Hemovent GmbH
  • 15.8. Kewei Medical
  • 15.9. LivaNova PLC
  • 15.10. Medtronic plc
  • 15.11. MicroPort Scientific Corporation
  • 15.12. Nikkiso Co., Ltd.
  • 15.13. Nipro Corporation
  • 15.14. Terumo Corporation
  • 15.15. Xenios AG

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Cardiopulmonary Assisted Membrane Oxygenator Market, Years Considered for the Study
  • FIGURE 2. Global Cardiopulmonary Assisted Membrane Oxygenator Market, Research Design
  • FIGURE 3. Global Cardiopulmonary Assisted Membrane Oxygenator Market, Research Framework
  • FIGURE 4. Global Cardiopulmonary Assisted Membrane Oxygenator Market, Data Triangulation
  • FIGURE 5. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 9. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2025 vs 2032 (%)
  • FIGURE 11. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Cardiopulmonary Assisted Membrane Oxygenator Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Cardiopulmonary Assisted Membrane Oxygenator Market Segmentation & Coverage
  • TABLE 2. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Disposable Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Disposable Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Disposable Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Polymethylpentene Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Polymethylpentene Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Polymethylpentene Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Polypropylene Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Polypropylene Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Polypropylene Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Silicone Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Silicone Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Silicone Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Reusable Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Reusable Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Reusable Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Polymethylpentene Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Polymethylpentene Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Polymethylpentene Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Polypropylene Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Polypropylene Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Polypropylene Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Silicone Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Silicone Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Silicone Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 29. Global Adult Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Adult Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Adult Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Cardiac Failure Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Cardiac Failure Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Cardiac Failure Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Respiratory Failure Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Respiratory Failure Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Respiratory Failure Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Neonatal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Neonatal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Neonatal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 45. Global Arteriovenous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Arteriovenous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Arteriovenous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Venoarterial Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Venoarterial Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Venoarterial Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Venovenous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Venovenous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Venovenous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 55. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Private Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Private Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Private Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Public Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Public Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Public Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 73. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 74. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 75. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 76. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 77. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 78. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 79. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 80. North America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. North America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 82. North America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 83. North America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 84. North America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 85. North America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 86. North America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 87. North America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 88. North America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 89. Latin America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Latin America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 91. Latin America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 92. Latin America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 93. Latin America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 94. Latin America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 95. Latin America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 96. Latin America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 97. Latin America Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 98. Europe Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Europe Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 100. Europe Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 101. Europe Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 102. Europe Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 103. Europe Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 104. Europe Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 105. Europe Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 106. Europe Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 107. Middle East Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 108. Middle East Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 109. Middle East Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 110. Middle East Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 111. Middle East Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 112. Middle East Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 113. Middle East Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 114. Middle East Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 115. Middle East Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 116. Africa Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 117. Africa Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 118. Africa Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 119. Africa Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 120. Africa Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 121. Africa Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 122. Africa Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 123. Africa Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 124. Africa Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 125. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 126. ASEAN Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. ASEAN Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 128. ASEAN Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 129. ASEAN Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 130. ASEAN Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 131. ASEAN Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 132. ASEAN Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 133. ASEAN Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 134. ASEAN Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 135. GCC Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 136. GCC Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 137. GCC Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 138. GCC Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 139. GCC Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 140. GCC Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 141. GCC Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 142. GCC Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 143. GCC Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 144. European Union Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 145. European Union Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 146. European Union Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 147. European Union Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 148. European Union Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 149. European Union Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 150. European Union Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 151. European Union Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 152. European Union Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 153. BRICS Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 154. BRICS Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 155. BRICS Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 156. BRICS Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 157. BRICS Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 158. BRICS Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 159. BRICS Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 160. BRICS Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 161. BRICS Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 162. G7 Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 163. G7 Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 164. G7 Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 165. G7 Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 166. G7 Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 167. G7 Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 168. G7 Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 169. G7 Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 170. G7 Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 171. NATO Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 172. NATO Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 173. NATO Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 174. NATO Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 175. NATO Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 176. NATO Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 177. NATO Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 178. NATO Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 179. NATO Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 180. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 181. United States Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 182. United States Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 183. United States Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 184. United States Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 185. United States Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 186. United States Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 187. United States Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 188. United States Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 189. United States Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 190. Canada Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 191. Canada Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 192. Canada Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 193. Canada Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 194. Canada Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 195. Canada Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 196. Canada Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 197. Canada Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 198. Canada Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 199. Mexico Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 200. Mexico Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 201. Mexico Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 202. Mexico Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 203. Mexico Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 204. Mexico Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 205. Mexico Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 206. Mexico Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 207. Mexico Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 208. Brazil Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 209. Brazil Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 210. Brazil Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 211. Brazil Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 212. Brazil Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 213. Brazil Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 214. Brazil Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 215. Brazil Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 216. Brazil Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 217. United Kingdom Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 218. United Kingdom Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 219. United Kingdom Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 220. United Kingdom Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 221. United Kingdom Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 222. United Kingdom Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 223. United Kingdom Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 224. United Kingdom Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 225. United Kingdom Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 226. Germany Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 227. Germany Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 228. Germany Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 229. Germany Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 230. Germany Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 231. Germany Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 232. Germany Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 233. Germany Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 234. Germany Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 235. France Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 236. France Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 237. France Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 238. France Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 239. France Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 240. France Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 241. France Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 242. France Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 243. France Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 244. Russia Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 245. Russia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 246. Russia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 247. Russia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 248. Russia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 249. Russia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 250. Russia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 251. Russia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 252. Russia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 253. Italy Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 254. Italy Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 255. Italy Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 256. Italy Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 257. Italy Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 258. Italy Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 259. Italy Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 260. Italy Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 261. Italy Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 262. Spain Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 263. Spain Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 264. Spain Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 265. Spain Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 266. Spain Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 267. Spain Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 268. Spain Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 269. Spain Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 270. Spain Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 271. China Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 272. China Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 273. China Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 274. China Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 275. China Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 276. China Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 277. China Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 278. China Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 279. China Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 280. India Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 281. India Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 282. India Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 283. India Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 284. India Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 285. India Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 286. India Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 287. India Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 288. India Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 289. Japan Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 290. Japan Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 291. Japan Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 292. Japan Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 293. Japan Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 294. Japan Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 295. Japan Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 296. Japan Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 297. Japan Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Hospitals, 2017-2032 (USD Million)
  • TABLE 298. Australia Cardiopulmonary Assisted Membrane Oxygenator Market Size, 2017-2032 (USD Million)
  • TABLE 299. Australia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 300. Australia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Disposable, 2017-2032 (USD Million)
  • TABLE 301. Australia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Reusable, 2017-2032 (USD Million)
  • TABLE 302. Australia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 303. Australia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Adult, 2017-2032 (USD Million)
  • TABLE 304. Australia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by Mode of Operation, 2017-2032 (USD Million)
  • TABLE 305. Australia Cardiopulmonary Assisted Membrane Oxygenator Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 306. Australia Cardiopulmonary Assisted Membr